298 related articles for article (PubMed ID: 29538739)
1. Candida vaginitis: virulence, host response and vaccine prospects.
De Bernardis F; Graziani S; Tirelli F; Antonopoulou S
Med Mycol; 2018 Apr; 56(suppl_1):26-31. PubMed ID: 29538739
[TBL] [Abstract][Full Text] [Related]
2. A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine.
Sandini S; La Valle R; Deaglio S; Malavasi F; Cassone A; De Bernardis F
FEMS Immunol Med Microbiol; 2011 Jul; 62(2):215-24. PubMed ID: 21535228
[TBL] [Abstract][Full Text] [Related]
3. A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models.
De Bernardis F; Amacker M; Arancia S; Sandini S; Gremion C; Zurbriggen R; Moser C; Cassone A
Vaccine; 2012 Jun; 30(30):4490-8. PubMed ID: 22561143
[TBL] [Abstract][Full Text] [Related]
4. Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice.
Pericolini E; Gabrielli E; Amacker M; Kasper L; Roselletti E; Luciano E; Sabbatini S; Kaeser M; Moser C; Hube B; Vecchiarelli A; Cassone A
mBio; 2015 Jun; 6(3):e00724. PubMed ID: 26037125
[TBL] [Abstract][Full Text] [Related]
5. Studies of Immune Responses in Candida vaginitis.
De Bernardis F; Arancia S; Sandini S; Graziani S; Norelli S
Pathogens; 2015 Oct; 4(4):697-707. PubMed ID: 26473934
[TBL] [Abstract][Full Text] [Related]
6. Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis.
Schaller M; Korting HC; Borelli C; Hamm G; Hube B
Infect Immun; 2005 May; 73(5):2758-65. PubMed ID: 15845479
[TBL] [Abstract][Full Text] [Related]
7. Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis.
De Bernardis F; Liu H; O'Mahony R; La Valle R; Bartollino S; Sandini S; Grant S; Brewis N; Tomlinson I; Basset RC; Holton J; Roitt IM; Cassone A
J Infect Dis; 2007 Jan; 195(1):149-57. PubMed ID: 17152019
[TBL] [Abstract][Full Text] [Related]
8. Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects.
Cassone A
BJOG; 2015 May; 122(6):785-794. PubMed ID: 25052208
[TBL] [Abstract][Full Text] [Related]
9. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with Secreted Aspartyl Proteinase 2 Protein from
Shukla M; Rohatgi S
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32661125
[TBL] [Abstract][Full Text] [Related]
11. The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium.
Schaller M; Bein M; Korting HC; Baur S; Hamm G; Monod M; Beinhauer S; Hube B
Infect Immun; 2003 Jun; 71(6):3227-34. PubMed ID: 12761103
[TBL] [Abstract][Full Text] [Related]
12. NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.
Ibrahim AS; Luo G; Gebremariam T; Lee H; Schmidt CS; Hennessey JP; French SW; Yeaman MR; Filler SG; Edwards JE
Vaccine; 2013 Nov; 31(47):5549-56. PubMed ID: 24063977
[TBL] [Abstract][Full Text] [Related]
13. Anticandidal immunity and vaginitis: novel opportunities for immune intervention.
Cassone A; De Bernardis F; Santoni G
Infect Immun; 2007 Oct; 75(10):4675-86. PubMed ID: 17562759
[No Abstract] [Full Text] [Related]
14. Protective antigens and mechanisms of anti-Candida immunity.
Antonio C
Nihon Ishinkin Gakkai Zasshi; 2000; 41(4):219. PubMed ID: 11064318
[TBL] [Abstract][Full Text] [Related]
15. Saccharomyces cerevisiae-based probiotic as novel anti-fungal and anti-inflammatory agent for therapy of vaginal candidiasis.
Gabrielli E; Pericolini E; Ballet N; Roselletti E; Sabbatini S; Mosci P; Decherf AC; Pélerin F; Perito S; Jüsten P; Vecchiarelli A
Benef Microbes; 2018 Feb; 9(2):219-230. PubMed ID: 29380641
[TBL] [Abstract][Full Text] [Related]
16. Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB/c mice.
Wang Y; Su Q; Dong S; Shi H; Gao X; Wang L
Hum Vaccin Immunother; 2014; 10(4):1057-63. PubMed ID: 24448202
[TBL] [Abstract][Full Text] [Related]
17. Increased severity of Candida vaginitis in BALB/c nu/nu mice versus the parent strain is not abrogated by adoptive transfer of T cell enriched lymphocytes.
Black CA; Eyers FM; Russell A; Dunkley ML; Clancy RL; Beagley KW
J Reprod Immunol; 1999 Nov; 45(1):1-18. PubMed ID: 10660259
[TBL] [Abstract][Full Text] [Related]
18. Comparative Analysis of the Capacity of the
Willems HME; Lowes DJ; Barker KS; Palmer GE; Peters BM
Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30249743
[TBL] [Abstract][Full Text] [Related]
19. Candidalysin Drives Epithelial Signaling, Neutrophil Recruitment, and Immunopathology at the Vaginal Mucosa.
Richardson JP; Willems HME; Moyes DL; Shoaie S; Barker KS; Tan SL; Palmer GE; Hube B; Naglik JR; Peters BM
Infect Immun; 2018 Feb; 86(2):. PubMed ID: 29109176
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic analysis of vulvovaginal candidiasis identifies a role for the NLRP3 inflammasome.
Bruno VM; Shetty AC; Yano J; Fidel PL; Noverr MC; Peters BM
mBio; 2015 Apr; 6(2):. PubMed ID: 25900651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
